COVID-19 has changed the way we work and live. In response to the public health emergency, Milken Institute Chairman Michael Milken is engaging a range of industry leaders and medical experts to help us better understand and confront a crisis that has not only altered our current day-to-day but will change the course of how we work, socialize, and fight disease for years to come.
All content for Conversations with Mike Milken is the property of Milken Institute and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
COVID-19 has changed the way we work and live. In response to the public health emergency, Milken Institute Chairman Michael Milken is engaging a range of industry leaders and medical experts to help us better understand and confront a crisis that has not only altered our current day-to-day but will change the course of how we work, socialize, and fight disease for years to come.
Ep. 109: Lessons Learned: The Intersection of Cancer Research and COVID Treatments
Conversations with Mike Milken
39 minutes 20 seconds
4 years ago
Ep. 109: Lessons Learned: The Intersection of Cancer Research and COVID Treatments
Himisha Beltran
Medical Oncologist, Dana-Farber Cancer Institute
Felix Feng
Radiation Oncologist and Vice Chair for Translational Research, UCSF Department of Radiation Oncology
Christopher Haiman
Genetic Epidemiologist and Professor of Preventive Medicine, Keck School of Medicine of USC
Deborah Scher
Executive Advisor to the Secretary, U.S. Department of Veterans Affairs (VA)
Jonathan Simons
President and CEO, Prostate Cancer Foundation (PCF)
“The road to curing COVID runs right through lots and lots of cancer research.” – Jonathan Simons, President and CEO, Prostate Cancer Foundation
Three top cancer researchers, the head of PCF, and a VA leader join Mike Milken to discuss how genomics, immunotherapies, and precision medicine are informing the quest for effective COVID vaccines and treatments.
The best practices developed by oncologists in the past two decades are now the standard of care at VA facilities across the country. In discussing the 2016 PCF/VA partnership that established Centers of Excellence, Deborah Scher notes the role oncology continues to play in the pandemic. “We have really built a community of researchers who are bringing best-in-class precision oncology to veterans across the country and are using that platform not just for prostate cancer innovation, but today for COVID innovation as well.”
Conversations with Mike Milken
COVID-19 has changed the way we work and live. In response to the public health emergency, Milken Institute Chairman Michael Milken is engaging a range of industry leaders and medical experts to help us better understand and confront a crisis that has not only altered our current day-to-day but will change the course of how we work, socialize, and fight disease for years to come.
